[1] |
李营, 束晓梅. 早发癫痫性脑病遗传学病因研究进展[J]. 临床儿科杂志, 2017, 35(11):864-867.
|
[2] |
Havrylenko S, Mirande M. Aminoacyl-tRNA synthetase complexes in evolution[J]. Int J Mol Sci, 2015, 16(3):6571-6594.
doi: 10.3390/ijms16036571
pmid: 25807264
|
[3] |
Noh GJ, Jane Tavyev Asher Y, Graham JM Jr. Clinical review of genetic epileptic encephalopathies[J]. Eur J Med Genet, 2012, 55(5):281-298.
doi: 10.1016/j.ejmg.2011.12.010
|
[4] |
田杨, 侯池, 王秀英, 等. SLC35A2基因突变致马凡综合征家系中 West 综合征患儿 1 例分析并文献复习[J]. 临床儿科杂志, 2020, 38(4):302-305.
|
[5] |
Nashabat M, Al Qahtani XS, Almakdob S, et al. The landscape of early infantile epileptic cencephalopathy in a consanguineous population[J]. Seizure, 2019, 69:154-172.
doi: S1059-1311(18)30644-7
pmid: 31054490
|
[6] |
Suzuki T, Nagao A, Suzuki T. Human mitochondrial tRNAs: biogenesis, function, structural aspects, and diseases[J]. Annu Rev Genet, 2011, 45:299-329.
doi: 10.1146/genet.2011.45.issue-1
|
[7] |
Sissler M, González-Serrano LE, Westhof E. Recent advances in mitochondrial aminoacyl-tRNA synthetases and disease[J]. Trends Mol Med, 2017, 23(8):693-708.
doi: S1471-4914(17)30099-0
pmid: 28716624
|
[8] |
Sofou K, Kollberg G, Holmström M, et al. Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome[J]. Mol Genet Genomic Med, 2015, 3(1):59-68.
doi: 10.1002/mgg3.2015.3.issue-1
|
[9] |
Sofou K, Moslemi AR, Kollberg G, et al. Phenotypic and genotypic variability in Alpers syndrome[J]. Eur J Paediatr Neurol, 2012, 16(4):379-389.
doi: 10.1016/j.ejpn.2011.12.006
|
[10] |
Yin X, Tang B, Mao X, et al. The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy[J]. J Hum Genet, 2018, 63(9):971-980.
doi: 10.1038/s10038-018-0478-z
|
[11] |
Mizuguchi T, Nakashima M, Kato M, et al. PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder[J]. J Hum Genet, 2017, 62(5):525-529.
doi: 10.1038/jhg.2016.163
pmid: 28077841
|
[12] |
Ciara E, Rokicki D, Lazniewski M, et al. Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations[J]. J Hum Genet, 2018, 63(4):473-485.
doi: 10.1038/s10038-017-0401-z
|
[13] |
Almuqbil M, Vernon HJ, Ferguson M, et al. PARS2-associated mitochondrial disease: a case report of a patient with prolonged survival and literature review[J]. Mol Genet Metab Rep, 2020, 24:100613.
|
[14] |
Pronicka E, Piekutowska-Abramczuk D, Ciara E, et al. New perspective in diagnostics of mitochondrial disorders: two years’experience with whole-exome sequencing at a national paediatric centre[J]. J Transl Med, 2016, 14(1):174.
doi: 10.1186/s12967-016-0930-9
pmid: 27290639
|